Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2003
08/28/2003WO2002081687A3 Yeast genes that affect viral replication
08/28/2003WO2002081628A8 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
08/28/2003WO2002054073A3 Latent human tuberculosis model, diagnostic antigens, and methods of use
08/28/2003WO2002036149A3 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
08/28/2003WO2002034940A3 Methods for screening compounds that modulate lipid metabolism
08/28/2003WO2002020756A3 Secretory molecules
08/28/2003WO2002012470A3 A member of the lysyl oxidase gene family
08/28/2003WO2001092307A3 Therapeutic compounds for ovarian cancer
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162945 G- protein coupled receptor org10
08/28/2003US20030162944 Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
08/28/2003US20030162740 Strategy for leukemia therapy
08/28/2003US20030162736 Medicament comprising NK4 gene or recombinant NK4 protein
08/28/2003US20030162735 Compound, composition and method for treatment of inflammatory and inflammatory-related disorders
08/28/2003US20030162719 Immobilization of active materials
08/28/2003US20030162717 Suppression appetite; weight loss therapy
08/28/2003US20030162715 Fertility; controlling cell differentiation
08/28/2003US20030162714 Modulate cell differentiation; muscular disorders; fat metabolism; bone disorders
08/28/2003US20030162709 Methods of generating multispecific, multivalent agents from VH and VL domains
08/28/2003US20030162293 Cell transfection compositions comprising genetic material, an amphipathic compound and an enzyme inhibitor and method of use
08/28/2003US20030162291 Clk-2, cex-7 and coq-4 genes, and uses thereof
08/28/2003US20030162252 Isolating cDNAs encoding novel G protein-coupled receptor proteins derived from human spleen
08/28/2003US20030162194 Diagnosis of diseases associated with apoptosis
08/28/2003US20030162186 Human cDNAs and proteins and uses thereof
08/28/2003US20030162176 Complementary DNAs
08/28/2003US20030162175 NK cell receptor polynucleotides, polypeptides, and antibodies
08/28/2003US20030161844 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
08/28/2003US20030161833 Chlamydia antigens and corresponding DNA fragments and uses thereof
08/28/2003US20030161818 Cultures, products and methods using stem cells
08/28/2003US20030161817 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
08/28/2003US20030161814 Adeno-associated virus-mediated delivery of GDNF to skeletal muscles
08/28/2003US20030161810 Methods and materials for treating inflammatory diseases
08/28/2003US20030161788 System for monitoring bacterial tumor treatment
08/28/2003CA2515243A1 Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent
08/28/2003CA2485882A1 A therapeutic agent for mycobacterium tuberculosis comprising 15k granulysin as the active ingredient
08/28/2003CA2477202A1 Cd40 splice variants, compositions for making and methods of using the same
08/28/2003CA2477014A1 Rna interference mediated inhibition of tnf and tnf receptor superfamily gene expression using short interfering nucleic acid (sina)
08/28/2003CA2476832A1 Use of an inhibitor or antagonist against tissue factor
08/28/2003CA2476452A1 Electroporation methods for introducing bioactive agents into cells
08/28/2003CA2476451A1 Hyaluronic acid mediated adenoviral transduction
08/28/2003CA2476437A1 Chemosensitizing with liposomes containing oligonucleotides
08/28/2003CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina)
08/28/2003CA2473133A1 Rrp sequences and knockout mice and uses thereof
08/28/2003CA2471421A1 Rna interference mediated inhibition of protein typrosine phosphatase-1b (ptp-1b) gene expression using short interfering nucleic acid (sina)
08/28/2003CA2463595A1 Rna interference mediated inhibition of bcl2 gene expression using short interfering nucleic acid (sina)
08/28/2003CA2460055A1 Insulin and igf-1 receptor agonists and antagonists
08/28/2003CA2459532A1 Rna interference by modified short interfering nucleic acid
08/28/2003CA2456444A1 Rna interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (sina)
08/28/2003CA2455506A1 Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina)
08/27/2003EP1338649A1 Novel gene overexpressed in heart and skeletal muscle and use tehreof
08/27/2003EP1338609A1 A further KDR receptor and the use thereof
08/27/2003EP1337850A1 Method for diagnosing a tumor in a patient determining the concentration of pibf
08/27/2003EP1337664A2 Method for introducing antisense oligonucleotides into eucaryotic cells
08/27/2003EP1337655A2 Retroviral vectors containing internal ribosomal entry sites
08/27/2003EP1337642A1 Cytokin-like proteins
08/27/2003EP1337641A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
08/27/2003EP1337640A2 NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379
08/27/2003EP1337639A2 Master bone formation transcription factor: compositions and methods of use
08/27/2003EP1337632A2 Differentiated cells suitable for human therapy
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337559A2 Regulation of human nmda receptor
08/27/2003EP1337285A1 Implants with a phosphazene-containing coating
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP1337275A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
08/27/2003EP1337259A2 Methylenetetrahydrofolate reductase inhibitors and use thereof
08/27/2003EP1337258A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof
08/27/2003EP1337242A2 Gene delivery formulations and methods for treatment of ischemic conditions
08/27/2003EP1267834A4 Cationic liposomes
08/27/2003EP1169046B1 Pulmonary delivery of protonated/acidified nucleic acids
08/27/2003EP1124577B1 USE OF AN ENTEROBACTERIUM PROTEIN OmpA FOR SPECIFIC TARGETING TOWARDS ANTIGEN-PRESENTING CELLS
08/27/2003EP1061935A4 Proapoptotic peptides, dependence polypeptides and methods of use
08/27/2003CN1439056A Herpes viruses for immune modulation
08/27/2003CN1439055A Novel recombinant adenovirus vector with relieved side effects
08/27/2003CN1438047A Method for quiding gene into local part or humanbody by shoe-type catheter
08/27/2003CN1119173C Methods for preparing gas-filled liposomes
08/27/2003CN1119145C Liposomal compositions and method of using them
08/26/2003US6610906 Nucleotide sequences for gene regulation and methods of use thereof
08/26/2003US6610842 Removing hydroxyl protecting group from compound of given formula and treating with another compound; wide range of diagnostic and therapeutic uses
08/26/2003US6610839 Promoter for telomerase reverse transcriptase
08/26/2003US6610829 Human extracellular matrix-1
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610663 Antisense compound with targeting and RNA cleaving moieties, preferably an imidazole functionality conjugated to the targeting oligonucleotide via linkers
08/26/2003US6610650 Modulation of cellular transcription factor activity
08/26/2003US6610541 Recombinant, active caspases and uses thereof
08/26/2003US6610540 Low oxygen culturing of central nervous system progenitor cells
08/26/2003US6610535 Progenitor cells and methods and uses related thereto
08/26/2003US6610534 Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases
08/26/2003US6610532 Treating or preventing heart defects in mammals; obtain human, administer modulator, monitor humans for adjustment in heart activity
08/26/2003US6610523 Human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating
08/26/2003US6610512 Zinc finger binding domains for GNN
08/26/2003US6610508 Translation driver system and methods for use thereof
08/26/2003US6610480 Identification of genes which are differentially expressed in hypertrophic cardiac tissue as compared to normal cardiac tissue. Accordingly, the present invention provides nucleotide sequences of genes and promotion or inhibition of the function
08/26/2003US6610477 Human DNA mismatch repair proteins
08/26/2003US6610321 Emulsion formulations for hydrophilic active agents
08/26/2003US6610309 Vaccines; mixture of antigen and water solubility organometallic compound
08/26/2003US6610307 Immunity against pasteurella haemolytica leukotoxin
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610290 Transferring preferential nucleotide sequences to cells; obtain cells, incubate with expression vector, transform cells, recover transformed cells
08/26/2003US6610289 Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
1 ... 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 ... 870